Literature DB >> 18697946

The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles.

Shaodong Dai1, Frances Crawford, Philippa Marrack, John W Kappler.   

Abstract

Class II major histocompatibility complex (MHCII) molecules present antigens to CD4(+) T cells. In addition to the most commonly studied human MHCII isotype, HLA-DR, whose beta chain is encoded by the HLA-DRB1 locus, several other isotypes that use the same alpha chain but have beta chains encoded by other genes. These other DR molecules also are expressed in antigen-presenting cells and are known to participate in peptide presentation to T cells and to be recognized as alloantigens by other T cells. Like some of the HLA-DRB1 alleles, several of these alternate DR molecules have been associated with specific autoimmune diseases and T cell hypersensitivity. Here we present the structure of an HLA-DR molecule (DR52c) containing one of these alternate beta chains (HLA-DRB3*0301) bound to a self-peptide derived from the Tu elongation factor. The molecule shares structurally conserved elements with other MHC class II molecules but has some unique features in the peptide-binding groove. Comparison of the three major HLA-DBR3 alleles (DR52a, b, and c) suggests that they were derived from one another by recombination events that scrambled the four major peptide-binding pockets at peptide positions 1, 4, 6, and 9 but left virtually no polymorphisms elsewhere in the molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697946      PMCID: PMC2515224          DOI: 10.1073/pnas.0805810105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

Authors:  A T Brünger
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

2.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

Review 3.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

4.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

5.  Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity.

Authors:  J Gorski; B Mach
Journal:  Nature       Date:  1986 Jul 3-9       Impact factor: 49.962

6.  Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice.

Authors:  S K Lawrance; L Karlsson; J Price; V Quaranta; Y Ron; J Sprent; P A Peterson
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

7.  HLA-DRB1 and -DRB3 allele frequencies and haplotypic associations in Koreans.

Authors:  Eun Young Song; Hyejin Park; Eun Youn Roh; Myoung Hee Park
Journal:  Hum Immunol       Date:  2004-03       Impact factor: 2.850

8.  Components of the ligand for a Ni++ reactive human T cell clone.

Authors:  Linh Lu; Jörg Vollmer; Corinne Moulon; Hans Ulrich Weltzien; Philippa Marrack; John Kappler
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

9.  Correlation of structure with T cell responses of the three members of the HLA-DRw52 allelic series.

Authors:  J Gorski; C Irle; E M Mickelson; M J Sheehy; A Termijtelen; C Ucla; B Mach
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children.

Authors:  Hyun Hee Oh; Soon Hak Kwon; Chang Woo Kim; Byung Ho Choe; Cheol Woo Ko; Hee Du Jung; Jang Soo Suh; Jun Hwa Lee
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more
  12 in total

Review 1.  Linkers in the structural biology of protein-protein interactions.

Authors:  Vishnu Priyanka Reddy Chichili; Veerendra Kumar; J Sivaraman
Journal:  Protein Sci       Date:  2013-01-08       Impact factor: 6.725

2.  Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.

Authors:  Maha Ayyoub; Danijel Dojcinovic; Pascale Pignon; Isabelle Raimbaud; Julien Schmidt; Immanuel Luescher; Danila Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 3.  Major histocompatibility complex variation and the evolution of resistance to amphibian chytridiomycosis.

Authors:  Minjie Fu; Bruce Waldman
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

4.  Using DR52c/Ni2+ mimotope tetramers to detect Ni2+ reactive CD4+ T cells in patients with joint replacement failure.

Authors:  Yan Zhang; Yang Wang; Kirsten Anderson; Andrey Novikov; Zikou Liu; Karin Pacheco; Shaodong Dai
Journal:  Toxicol Appl Pharmacol       Date:  2017-05-26       Impact factor: 4.219

5.  T-cell receptor (TCR) interaction with peptides that mimic nickel offers insight into nickel contact allergy.

Authors:  Lei Yin; Frances Crawford; Philippa Marrack; John W Kappler; Shaodong Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

6.  Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.

Authors:  Rosa Faner; Eddie James; Laurie Huston; Ricardo Pujol-Borrel; William W Kwok; Manel Juan
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

Review 7.  Structural basis of metal hypersensitivity.

Authors:  Yang Wang; Shaodong Dai
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

8.  An automated framework for understanding structural variations in the binding grooves of MHC class II molecules.

Authors:  Kalidas Yeturu; Tapani Utriainen; Graham J L Kemp; Nagasuma Chandra
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

9.  The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression.

Authors:  Thomas H P M Habets; Bouke G Hepkema; Niels Kouprie; Melanie C A Schnijderberg; Tim C van Smaalen; Laura B Bungener; Maarten H L Christiaans; Gerard M J Bos; Joris Vanderlocht
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

10.  Next generation sequencing reveals the association of DRB3*02:02 with type 1 diabetes.

Authors:  Henry A Erlich; Ana Maria Valdes; Shana L McDevitt; Birgitte B Simen; Lisbeth A Blake; Kim R McGowan; John A Todd; Stephen S Rich; Janelle A Noble
Journal:  Diabetes       Date:  2013-03-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.